These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15033590)

  • 21. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Toxicol Sci; 2004 Jan; 77(1):19-34. PubMed ID: 14600272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systems toxicology used in nanotoxicology: mechanistic insights into the hepatotoxicity of nano-copper particles from toxicogenomics.
    Yang B; Wang Q; Lei R; Wu C; Shi C; Wang Q; Yuan Y; Wang Y; Luo Y; Hu Z; Ma H; Liao M
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8527-37. PubMed ID: 21121362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a toxicogenomics signature for genotoxicity using a dose-optimization and informatics strategy in human cells.
    Li HH; Hyduke DR; Chen R; Heard P; Yauk CL; Aubrecht J; Fornace AJ
    Environ Mol Mutagen; 2015 Jul; 56(6):505-19. PubMed ID: 25733355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA microarrays in clinical cancer research.
    Wadlow R; Ramaswamy S
    Curr Mol Med; 2005 Feb; 5(1):111-20. PubMed ID: 15720274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA; Bruno ME
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals.
    Li HH; Aubrecht J; Fornace AJ
    Mutat Res; 2007 Oct; 623(1-2):98-108. PubMed ID: 17548094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel transcriptomics based in vitro method to compare and predict hepatotoxicity based on mode of action.
    De Abrew KN; Overmann GJ; Adams RL; Tiesman JP; Dunavent J; Shan YK; Carr GJ; Daston GP; Naciff JM
    Toxicology; 2015 Feb; 328():29-39. PubMed ID: 25475144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The state-of-the-art in predictive toxicogenomics.
    Fielden MR; Kolaja KL
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent applications of DNA microarray technology to toxicology and ecotoxicology.
    Lettieri T
    Environ Health Perspect; 2006 Jan; 114(1):4-9. PubMed ID: 16393650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of genotoxicant-modified transcriptomic responses in conventional and epigenetically stabilized primary rat hepatocytes with in vivo rat liver data.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Nov; 86(11):1703-15. PubMed ID: 23052194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in applying genomics in drug development.
    Lord PG
    Toxicol Lett; 2004 Apr; 149(1-3):371-5. PubMed ID: 15093283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic-based biomarkers of drug-induced nephrotoxicity.
    Davis JW; Kramer JA
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):95-101. PubMed ID: 16863471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research.
    Tong W; Cao X; Harris S; Sun H; Fang H; Fuscoe J; Harris A; Hong H; Xie Q; Perkins R; Shi L; Casciano D
    Environ Health Perspect; 2003 Nov; 111(15):1819-26. PubMed ID: 14630514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of DNA microarray to toxicological research.
    Shioda T
    J Environ Pathol Toxicol Oncol; 2004; 23(1):13-31. PubMed ID: 14994992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicogenomics: an emerging discipline.
    Schmidt CW
    Environ Health Perspect; 2002 Dec; 110(12):A750-5. PubMed ID: 12460812
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds.
    Josse R; Dumont J; Fautrel A; Robin MA; Guillouzo A
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):176-87. PubMed ID: 22100608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.
    Irwin RD; Boorman GA; Cunningham ML; Heinloth AN; Malarkey DE; Paules RS
    Toxicol Pathol; 2004; 32 Suppl 1():72-83. PubMed ID: 15209406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.